1675 related articles for article (PubMed ID: 11062605)
1. Active synovial matrix metalloproteinase-2 is associated with radiographic erosions in patients with early synovitis.
Goldbach-Mansky R; Lee JM; Hoxworth JM; Smith D; Duray P; Schumacher RH; Yarboro CH; Klippel J; Kleiner D; El-Gabalawy HS
Arthritis Res; 2000; 2(2):145-53. PubMed ID: 11062605
[TBL] [Abstract][Full Text] [Related]
2. Gelatinase expression and activity in the synovium and skin of patients with erosive psoriatic arthritis.
Hitchon CA; Danning CL; Illei GG; El-Gabalawy HS; Boumpas DT
J Rheumatol; 2002 Jan; 29(1):107-17. PubMed ID: 11824946
[TBL] [Abstract][Full Text] [Related]
3. Involvement of matrix metalloproteinases and their inhibitors in peripheral synovitis and down-regulation by tumor necrosis factor alpha blockade in spondylarthropathy.
Vandooren B; Kruithof E; Yu DT; Rihl M; Gu J; De Rycke L; Van Den Bosch F; Veys EM; De Keyser F; Baeten D
Arthritis Rheum; 2004 Sep; 50(9):2942-53. PubMed ID: 15457463
[TBL] [Abstract][Full Text] [Related]
4. Early joint erosions and serum levels of matrix metalloproteinase 1, matrix metalloproteinase 3, and tissue inhibitor of metalloproteinases 1 in rheumatoid arthritis.
Cunnane G; Fitzgerald O; Beeton C; Cawston TE; Bresnihan B
Arthritis Rheum; 2001 Oct; 44(10):2263-74. PubMed ID: 11665967
[TBL] [Abstract][Full Text] [Related]
5. Synovial tissue protease gene expression and joint erosions in early rheumatoid arthritis.
Cunnane G; FitzGerald O; Hummel KM; Youssef PP; Gay RE; Gay S; Bresnihan B
Arthritis Rheum; 2001 Aug; 44(8):1744-53. PubMed ID: 11508424
[TBL] [Abstract][Full Text] [Related]
6. Examination of in vivo gelatinolytic activity in rheumatoid arthritis synovial tissue using newly developed in situ zymography and image analyzer.
Yoshida W; Uzuki M; Nishida J; Shimamura T; Sawai T
Clin Exp Rheumatol; 2009; 27(4):587-93. PubMed ID: 19772789
[TBL] [Abstract][Full Text] [Related]
7. Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in different histological variants of rheumatoid synovitis.
Klimiuk PA; Sierakowski S; Latosiewicz R; Cylwik B; Skowronski J; Chwiecko J
Rheumatology (Oxford); 2002 Jan; 41(1):78-87. PubMed ID: 11792884
[TBL] [Abstract][Full Text] [Related]
8. Expression of matrix metalloproteinase 9 (96-kd gelatinase B) in human rheumatoid arthritis.
Ahrens D; Koch AE; Pope RM; Stein-Picarella M; Niedbala MJ
Arthritis Rheum; 1996 Sep; 39(9):1576-87. PubMed ID: 8814070
[TBL] [Abstract][Full Text] [Related]
9. Reduced chemokine and matrix metalloproteinase expression in patients with rheumatoid arthritis achieving remission.
Katrib A; Smith MD; Ahern MJ; Slavotinek J; Stafford L; Cuello C; Bertouch JV; McNeil HP; Youssef PP
J Rheumatol; 2003 Jan; 30(1):10-21. PubMed ID: 12508384
[TBL] [Abstract][Full Text] [Related]
10. Quantitation of metalloproteinase gene expression in rheumatoid and psoriatic arthritis synovial tissue distal and proximal to the cartilage-pannus junction.
Kane D; Jensen LE; Grehan S; Whitehead AS; Bresnihan B; Fitzgerald O
J Rheumatol; 2004 Jul; 31(7):1274-80. PubMed ID: 15229943
[TBL] [Abstract][Full Text] [Related]
11. MMP-2, MMP-9, TIMP-1 and TIMP-2 levels in patients with rheumatoid arthritis and psoriatic arthritis.
Giannelli G; Erriquez R; Iannone F; Marinosci F; Lapadula G; Antonaci S
Clin Exp Rheumatol; 2004; 22(3):335-8. PubMed ID: 15144129
[TBL] [Abstract][Full Text] [Related]
12. Acute-phase serum amyloid A regulates tumor necrosis factor α and matrix turnover and predicts disease progression in patients with inflammatory arthritis before and after biologic therapy.
Connolly M; Mullan RH; McCormick J; Matthews C; Sullivan O; Kennedy A; FitzGerald O; Poole AR; Bresnihan B; Veale DJ; Fearon U
Arthritis Rheum; 2012 Apr; 64(4):1035-45. PubMed ID: 22076945
[TBL] [Abstract][Full Text] [Related]
13. Turnover of type II collagen and aggrecan in cartilage matrix at the onset of inflammatory arthritis in humans: relationship to mediators of systemic and local inflammation.
Fraser A; Fearon U; Billinghurst RC; Ionescu M; Reece R; Barwick T; Emery P; Poole AR; Veale DJ
Arthritis Rheum; 2003 Nov; 48(11):3085-95. PubMed ID: 14613270
[TBL] [Abstract][Full Text] [Related]
14. Matrix metalloproteinase-19 in capillary endothelial cells: expression in acutely, but not in chronically, inflamed synovium.
Kolb C; Mauch S; Krawinkel U; Sedlacek R
Exp Cell Res; 1999 Jul; 250(1):122-30. PubMed ID: 10388526
[TBL] [Abstract][Full Text] [Related]
15. New collagenolytic enzymes/cascade identified at the pannus-hard tissue junction in rheumatoid arthritis: destruction from above.
Konttinen YT; Ceponis A; Takagi M; Ainola M; Sorsa T; Sutinen M; Salo T; Ma J; Santavirta S; Seiki M
Matrix Biol; 1998 Dec; 17(8-9):585-601. PubMed ID: 9923652
[TBL] [Abstract][Full Text] [Related]
16. Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases 1 (TIMP-1), and MMP-1/TIMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis versus other surrogate markers.
Keyszer G; Lambiri I; Nagel R; Keysser C; Keysser M; Gromnica-Ihle E; Franz J; Burmester GR; Jung K
J Rheumatol; 1999 Feb; 26(2):251-8. PubMed ID: 9972954
[TBL] [Abstract][Full Text] [Related]
17. Activation of synovial fibroblasts in rheumatoid arthritis: lack of Expression of the tumour suppressor PTEN at sites of invasive growth and destruction.
Pap T; Franz JK; Hummel KM; Jeisy E; Gay R; Gay S
Arthritis Res; 2000; 2(1):59-64. PubMed ID: 11219390
[TBL] [Abstract][Full Text] [Related]
18. [Regulation of matrix-degrading enzymes in gynecologic cancer tissues and cells].
Kikkawa F
Nihon Sanka Fujinka Gakkai Zasshi; 1996 Aug; 48(8):618-22. PubMed ID: 8808829
[TBL] [Abstract][Full Text] [Related]
19. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression.
Hofmann UB; Westphal JR; Zendman AJ; Becker JC; Ruiter DJ; van Muijen GN
J Pathol; 2000 Jul; 191(3):245-56. PubMed ID: 10878545
[TBL] [Abstract][Full Text] [Related]
20. Modulation of inflammation and metalloproteinase expression in synovial tissue by leflunomide and methotrexate in patients with active rheumatoid arthritis. Findings in a prospective, randomized, double-blind, parallel-design clinical trial in thirty-nine patients at two centers.
Kraan MC; Reece RJ; Barg EC; Smeets TJ; Farnell J; Rosenburg R; Veale DJ; Breedveld FC; Emery P; Tak PP
Arthritis Rheum; 2000 Aug; 43(8):1820-30. PubMed ID: 10943872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
